2021 Form 10-K Financial Statement
#000165495422003008 Filed on March 11, 2022
Income Statement
Concept | 2021 | 2020 Q4 | 2020 |
---|---|---|---|
Revenue | $15.86M | $2.154M | $8.059M |
YoY Change | 96.8% | -48.78% | -37.87% |
Cost Of Revenue | $5.943M | $1.109M | $4.435M |
YoY Change | 34.0% | -46.19% | -34.94% |
Gross Profit | $9.917M | $1.045M | $3.624M |
YoY Change | 173.65% | -51.26% | -41.12% |
Gross Profit Margin | 62.53% | 48.51% | 44.97% |
Selling, General & Admin | $6.209M | $1.915M | $6.741M |
YoY Change | -7.89% | 32.34% | 16.53% |
% of Gross Profit | 62.61% | 183.25% | 186.01% |
Research & Development | $0.00 | $0.00 | $31.00K |
YoY Change | -100.0% | -100.0% | -71.82% |
% of Gross Profit | 0.0% | 0.0% | 0.86% |
Depreciation & Amortization | $7.380M | $3.020M | $11.34M |
YoY Change | -34.94% | 47.61% | 2.83% |
% of Gross Profit | 74.42% | 289.0% | 313.0% |
Operating Expenses | $19.53M | $4.935M | $41.88M |
YoY Change | -53.36% | 38.9% | 147.44% |
Operating Profit | -$1.867M | -$3.890M | -$33.82M |
YoY Change | -94.48% | 176.08% | 214.01% |
Interest Expense | $1.000K | $3.000K | $2.000K |
YoY Change | -50.0% | -90.91% | -100.26% |
% of Operating Profit | |||
Other Income/Expense, Net | $568.0K | -$181.0K | $1.132M |
YoY Change | -49.82% | -1745.45% | -1167.92% |
Pretax Income | -$1.299M | -$23.40M | -$32.69M |
YoY Change | -96.03% | 1244.0% | 194.45% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$1.299M | -$23.40M | -$32.69M |
YoY Change | -96.03% | 1244.0% | 194.45% |
Net Earnings / Revenue | -8.19% | -1086.3% | -405.63% |
Basic Earnings Per Share | -$0.02 | ||
Diluted Earnings Per Share | -$16.24K | -$322.9K | -$452.7K |
COMMON SHARES | |||
Basic Shares Outstanding | 20.00 shares | 450.0 shares | |
Diluted Shares Outstanding | 79.96M shares |
Balance Sheet
Concept | 2021 | 2020 Q4 | 2020 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $25.93M | $8.027M | $8.027M |
YoY Change | 223.03% | -64.19% | -64.19% |
Cash & Equivalents | $8.027M | ||
Short-Term Investments | |||
Other Short-Term Assets | $326.0K | $66.00K | $66.00K |
YoY Change | 393.94% | -9.59% | -9.59% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $1.782M | $660.0K | $660.0K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $28.04M | $8.753M | $8.753M |
YoY Change | 220.32% | -67.69% | -67.69% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $66.64M | $67.27M | $67.27M |
YoY Change | -0.93% | -27.05% | -27.05% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $3.543M | $3.543M | $3.543M |
YoY Change | 0.0% | -1.53% | -1.53% |
Total Long-Term Assets | $70.18M | $70.81M | $70.81M |
YoY Change | -0.89% | -26.09% | -26.09% |
TOTAL ASSETS | |||
Total Short-Term Assets | $28.04M | $8.753M | $8.753M |
Total Long-Term Assets | $70.18M | $70.81M | $70.81M |
Total Assets | $98.22M | $79.56M | $79.56M |
YoY Change | 23.45% | -35.26% | -35.26% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.626M | $212.0K | $212.0K |
YoY Change | 1138.68% | -98.25% | -98.25% |
Accrued Expenses | $1.568M | $303.0K | $408.0K |
YoY Change | 284.31% | -85.36% | -80.28% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | $288.0K | $288.0K |
YoY Change | -100.0% | ||
Total Short-Term Liabilities | $5.181M | $1.978M | $1.978M |
YoY Change | 161.93% | -87.0% | -87.0% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $82.00K | $82.00K |
YoY Change | -100.0% | ||
Other Long-Term Liabilities | $1.557M | $1.868M | $1.868M |
YoY Change | -16.65% | -14.08% | -14.08% |
Total Long-Term Liabilities | $1.557M | $1.950M | $1.950M |
YoY Change | -20.15% | -10.3% | -10.3% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $5.181M | $1.978M | $1.978M |
Total Long-Term Liabilities | $1.557M | $1.950M | $1.950M |
Total Liabilities | $6.738M | $3.928M | $3.928M |
YoY Change | 71.54% | -77.42% | -77.42% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$128.3M | ||
YoY Change | |||
Common Stock | $72.00K | ||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $91.48M | $75.64M | $75.64M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $98.22M | $79.56M | $79.56M |
YoY Change | 23.45% | -35.26% | -35.26% |
Cashflow Statement
Concept | 2021 | 2020 Q4 | 2020 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.299M | -$23.40M | -$32.69M |
YoY Change | -96.03% | 1244.0% | 194.45% |
Depreciation, Depletion And Amortization | $7.380M | $3.020M | $11.34M |
YoY Change | -34.94% | 47.61% | 2.83% |
Cash From Operating Activities | $5.970M | $36.00K | $12.00K |
YoY Change | 49650.0% | -100.75% | -99.28% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$4.632M | -$391.0K | -$14.77M |
YoY Change | -68.64% | -94.17% | -63.89% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $1.871M | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Cash From Investing Activities | -$2.761M | -$391.0K | -$14.77M |
YoY Change | -81.31% | -94.17% | -62.83% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $14.69M | $0.00 | |
YoY Change | -100.0% | ||
Debt Paid & Issued, Net | $0.00 | $370.0K | |
YoY Change | -100.0% | ||
Cash From Financing Activities | $14.69M | 0.000 | $370.0K |
YoY Change | 3871.35% | -99.36% | |
NET CHANGE | |||
Cash From Operating Activities | $5.970M | 36.00K | $12.00K |
Cash From Investing Activities | -$2.761M | -391.0K | -$14.77M |
Cash From Financing Activities | $14.69M | 0.000 | $370.0K |
Net Change In Cash | $17.90M | -355.0K | -$14.39M |
YoY Change | -224.43% | -96.92% | -172.18% |
FREE CASH FLOW | |||
Cash From Operating Activities | $5.970M | $36.00K | $12.00K |
Capital Expenditures | -$4.632M | -$391.0K | -$14.77M |
Free Cash Flow | $10.60M | $427.0K | $14.78M |
YoY Change | -28.28% | -77.29% | -65.28% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021 | dei |
Auditor Location
AuditorLocation
|
Houston, Texas | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
25930000 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8027000 | USD |
CY2021Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
1782000 | USD |
CY2020Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
660000 | USD |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
326000 | USD |
CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
66000 | USD |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
28038000 | USD |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
8753000 | USD |
CY2021Q4 | us-gaap |
Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
|
63908000 | USD |
CY2020Q4 | us-gaap |
Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
|
66994000 | USD |
CY2021Q4 | us-gaap |
Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
|
2559000 | USD |
CY2020Q4 | us-gaap |
Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
|
4000 | USD |
CY2021Q4 | us-gaap |
Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
|
66467000 | USD |
CY2020Q4 | us-gaap |
Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
|
66998000 | USD |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
173000 | USD |
CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
270000 | USD |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3543000 | USD |
CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3543000 | USD |
CY2021Q4 | us-gaap |
Assets
Assets
|
98221000 | USD |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
114000 | USD |
CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
105000 | USD |
CY2021Q4 | us-gaap |
Asset Retirement Obligation Current
AssetRetirementObligationCurrent
|
49000 | USD |
CY2020Q4 | us-gaap |
Asset Retirement Obligation Current
AssetRetirementObligationCurrent
|
234000 | USD |
CY2020Q4 | us-gaap |
Assets
Assets
|
79564000 | USD |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2626000 | USD |
CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
212000 | USD |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1454000 | USD |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
303000 | USD |
CY2021Q4 | ped |
Revenue Payable
RevenuePayable
|
938000 | USD |
CY2020Q4 | ped |
Revenue Payable
RevenuePayable
|
836000 | USD |
CY2021Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
0 | USD |
CY2020Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
288000 | USD |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5181000 | USD |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1978000 | USD |
CY2021Q4 | us-gaap |
Oil And Gas Reclamation Liability Noncurrent
OilAndGasReclamationLiabilityNoncurrent
|
0 | USD |
CY2020Q4 | us-gaap |
Oil And Gas Reclamation Liability Noncurrent
OilAndGasReclamationLiabilityNoncurrent
|
82000 | USD |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
81000 | USD |
CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
195000 | USD |
CY2021Q4 | us-gaap |
Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
|
1476000 | USD |
CY2020Q4 | us-gaap |
Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
|
1673000 | USD |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
6738000 | USD |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
3928000 | USD |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
84236146 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
72463340 | shares |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
84000 | USD |
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
72000 | USD |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
220984000 | USD |
CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
203850000 | USD |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-129585000 | USD |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-128286000 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
91483000 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
75636000 | USD |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
98221000 | USD |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
79564000 | USD |
CY2021 | us-gaap |
Revenues
Revenues
|
15860000 | USD |
CY2020 | us-gaap |
Revenues
Revenues
|
8059000 | USD |
CY2021 | us-gaap |
Lease Cost
LeaseCost
|
5943000 | USD |
CY2020 | us-gaap |
Lease Cost
LeaseCost
|
4435000 | USD |
CY2021 | us-gaap |
Exploration Expense
ExplorationExpense
|
0 | USD |
CY2020 | us-gaap |
Exploration Expense
ExplorationExpense
|
31000 | USD |
CY2021 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6209000 | USD |
CY2020 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6741000 | USD |
CY2021 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
7380000 | USD |
CY2020 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
11343000 | USD |
CY2021 | us-gaap |
Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
|
0 | USD |
CY2020 | us-gaap |
Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
|
19331000 | USD |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
19532000 | USD |
CY2020 | us-gaap |
Operating Expenses
OperatingExpenses
|
41881000 | USD |
CY2021 | us-gaap |
Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
|
1805000 | USD |
CY2020 | us-gaap |
Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
|
0 | USD |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1867000 | USD |
CY2020 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1132000 | USD |
CY2021 | ped |
Increase Decrease On Gains Losses On Extinguishment Of Debt
IncreaseDecreaseOnGainsLossesOnExtinguishmentOfDebt
|
-374000 | USD |
CY2020 | ped |
Increase Decrease On Gains Losses On Extinguishment Of Debt
IncreaseDecreaseOnGainsLossesOnExtinguishmentOfDebt
|
0 | USD |
CY2020 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | USD |
CY2021 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
568000 | USD |
CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-33822000 | USD |
CY2021 | us-gaap |
Interest Expense
InterestExpense
|
1000 | USD |
CY2020 | us-gaap |
Interest Expense
InterestExpense
|
2000 | USD |
CY2021 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
15000 | USD |
CY2020 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
40000 | USD |
CY2021 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
180000 | USD |
CY2020 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1094000 | USD |
CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
374000 | USD |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1299000 | USD |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-32690000 | USD |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20.00 | shares |
CY2020 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
450 | shares |
CY2021 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-20.00 | USD |
CY2020 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-450 | USD |
CY2021 | ped |
Basic New
BasicNew
|
79963237000 | USD |
CY2020 | ped |
Basic New
BasicNew
|
72209553000 | USD |
CY2021 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
79963237000 | shares |
CY2020 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
72209553000 | shares |
CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
-1299000 | USD |
CY2020 | us-gaap |
Profit Loss
ProfitLoss
|
-32690000 | USD |
CY2021 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7380000 | USD |
CY2020 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
11343000 | USD |
CY2021 | us-gaap |
Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
|
0 | USD |
CY2020 | us-gaap |
Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
|
19331000 | USD |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2452000 | USD |
CY2020 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2824000 | USD |
CY2021 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | USD |
CY2020 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
24000 | USD |
CY2021 | us-gaap |
Gain Loss On Sale Of Oil And Gas Property
GainLossOnSaleOfOilAndGasProperty
|
-1805000 | USD |
CY2020 | us-gaap |
Gain Loss On Sale Of Oil And Gas Property
GainLossOnSaleOfOilAndGasProperty
|
0 | USD |
CY2021 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
97000 | USD |
CY2020 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
90000 | USD |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1122000 | USD |
CY2020 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
3942000 | USD |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-260000 | USD |
CY2020 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
7000 | USD |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-356000 | USD |
CY2020 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-3199000 | USD |
CY2021 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1155000 | USD |
CY2020 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-1669000 | USD |
CY2021 | ped |
Increase Decrease Accrued Expenses To Related Party
IncreaseDecreaseAccruedExpensesToRelatedParty
|
0 | USD |
CY2020 | ped |
Increase Decrease Accrued Expenses To Related Party
IncreaseDecreaseAccruedExpensesToRelatedParty
|
0 | USD |
CY2021 | ped |
Increase Decrease Revenue Payable
IncreaseDecreaseRevenuePayable
|
102000 | USD |
CY2020 | ped |
Increase Decrease Revenue Payable
IncreaseDecreaseRevenuePayable
|
9000 | USD |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
5970000 | USD |
CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
12000 | USD |
CY2021 | ped |
Cash Paid For Drilling Costs
CashPaidForDrillingCosts
|
-4597000 | USD |
CY2020 | ped |
Cash Paid For Drilling Costs
CashPaidForDrillingCosts
|
-14770000 | USD |
CY2021 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
35000 | USD |
CY2020 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
0 | USD |
CY2020 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
0 | USD |
CY2020 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
0 | USD |
CY2020 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2824000 | USD |
CY2020 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
0 | USD |
CY2021 | ped |
Increase Decrease On Proceeds From Sale Of Oil And Gas Property And Equipment
IncreaseDecreaseOnProceedsFromSaleOfOilAndGasPropertyAndEquipment
|
1871000 | USD |
CY2020 | ped |
Increase Decrease On Proceeds From Sale Of Oil And Gas Property And Equipment
IncreaseDecreaseOnProceedsFromSaleOfOilAndGasPropertyAndEquipment
|
0 | USD |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2761000 | USD |
CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-14770000 | USD |
CY2021 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
0 | USD |
CY2020 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
740000 | USD |
CY2021 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
0 | USD |
CY2020 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
370000 | USD |
CY2021 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
14694000 | USD |
CY2020 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
14694000 | USD |
CY2020 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
370000 | USD |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
17903000 | USD |
CY2020 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-14388000 | USD |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
25712000 | USD |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
29227000 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11324000 | USD |
CY2021 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2020 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2021 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
CY2020 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
CY2021 | ped |
Accrued Oil And Gas Development Costs
AccruedOilAndGasDevelopmentCosts
|
2412000 | USD |
CY2020 | ped |
Accrued Oil And Gas Development Costs
AccruedOilAndGasDevelopmentCosts
|
8827000 | USD |
CY2021 | us-gaap |
Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
|
319000 | USD |
CY2020 | us-gaap |
Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
|
439000 | USD |
CY2021 | ped |
Issuance Of Restricted Common Stock
IssuanceOfRestrictedCommonStock
|
1000 | USD |
CY2020 | ped |
Issuance Of Restricted Common Stock
IssuanceOfRestrictedCommonStock
|
1000 | USD |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
105502000 | USD |
CY2020 | ped |
Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
|
0 | USD |
CY2020 | ped |
Stock Rescinded During Period Value
StockRescindedDuringPeriodValue
|
0 | USD |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-32690000 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
75636000 | USD |
CY2021 | ped |
Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
|
0 | USD |
CY2021 | ped |
Stock Rescinded During Period Value
StockRescindedDuringPeriodValue
|
0 | USD |
CY2021 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
14694000 | USD |
CY2021 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
0 | USD |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2452000 | USD |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1299000 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
91483000 | USD |
CY2021 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><strong>Use of Estimates in Financial Statement Preparation. </strong>The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as certain financial statement disclosures. While management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from these estimates. Significant estimates generally include those with respect to the amount of recoverable oil and gas reserves, the fair value of financial instruments, oil and gas depletion, asset retirement obligations, and stock-based compensation.</p> | |
CY2021 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><strong>Concentrations of Credit Risk. </strong>Financial instruments which potentially subject the Company to concentrations of credit risk include cash deposits placed with financial institutions. The Company periodically assesses the financial condition of its financial institutions and considers any possible credit risk to be minimal.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Sales to two customers comprised 72% and 12%, respectively, of the Company’s total oil and gas revenues for the year ended December 31, 2021. The Company believes that, in the event that its primary customers are unable or unwilling to continue to purchase the Company’s production, there are a substantial number of alternative buyers for its production at comparable prices.</p> | |
CY2021Q4 | us-gaap |
Other Receivables
OtherReceivables
|
17000000 | USD |
CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1123435 | shares |
CY2020Q4 | ped |
Asset Retirement Costs
AssetRetirementCosts
|
1108 | USD |
CY2021Q4 | ped |
Asset Retirement Costs
AssetRetirementCosts
|
789 | USD |
CY2019Q4 | us-gaap |
Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
|
126114000 | USD |
CY2020Q4 | us-gaap |
Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
|
146950000 | USD |
CY2019Q4 | ped |
Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization
|
14896000 | USD |
CY2020Q4 | ped |
Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization
|
4000 | USD |
CY2019Q4 | ped |
Asset Retirement Costs
AssetRetirementCosts
|
1547 | USD |
CY2020Q4 | ped |
Asset Retirement Costs
AssetRetirementCosts
|
1108 | USD |
CY2019Q4 | us-gaap |
Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment
|
50709000 | USD |
CY2020Q4 | us-gaap |
Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment
|
81064000 | USD |
CY2019Q4 | us-gaap |
Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
|
91848000 | USD |
CY2020Q4 | us-gaap |
Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
|
66998000 | USD |
CY2021 | ped |
Purchase Price Payment
PurchasePricePayment
|
52000 | USD |
CY2020 | ped |
Capital Costs Incurred Recently Completed Wells
CapitalCostsIncurredRecentlyCompletedWells
|
5943000 | USD |
CY2021 | ped |
Capital Costs For Which Production Not Started
CapitalCostsForWhichProductionNotStarted
|
15294000 | USD |
CY2020 | us-gaap |
Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
|
19331000 | USD |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
|
16667 | shares |
CY2021Q1 | ped |
Underwriter Discount Percent
UnderwriterDiscountPercent
|
0.06 | pure |
CY2021Q1 | ped |
Net Proceeds
NetProceeds
|
8200000 | USD |
CY2021Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
4458600 | shares |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
1.57 | |
CY2021Q4 | ped |
Net Proceeds
NetProceeds
|
6500000 | USD |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
1499000 | shares |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
|
129000 | shares |
CY2021Q4 | ped |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
|
0.32 | |
CY2020Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
150329 | shares |
CY2020Q4 | ped |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
|
0.32 | |
CY2020Q4 | ped |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instuments Other Than Options Exercisable Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstumentsOtherThanOptionsExercisableIntrinsicValue
|
179000 | USD |
CY2021Q1 | ped |
Shares Of Restricted Common Stock
SharesOfRestrictedCommonStock
|
16667 | shares |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
55000 | shares |
CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
74000 | shares |
CY2021Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
|
1919000 | USD |
CY2020Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
|
2323000 | USD |
CY2021Q4 | ped |
Unamortized Stock Based Compensation Expense Restricted Stock Option
UnamortizedStockBasedCompensationExpenseRestrictedStockOption
|
866000 | USD |
CY2020Q4 | ped |
Unamortized Stock Based Compensation Expense Restricted Stock Option
UnamortizedStockBasedCompensationExpenseRestrictedStockOption
|
1144000 | USD |
CY2021Q1 | us-gaap |
Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
|
550000 | shares |
CY2021Q1 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
1.39 | |
CY2021Q1 | us-gaap |
Contract Termination Claims Description
ContractTerminationClaimsDescription
|
The options have a term of five years and fully vest in January 2024, with 33.3% vesting each subsequent year from the date of grant, contingent upon each recipient’s continued service with the Company | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
654000 | USD |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
|
0.0045 | pure |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P3Y6M | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.56 | pure |
CY2021Q1 | us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
86430 | shares |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
191999 | shares |
CY2021Q1 | ped |
Coomon Stock Market Value
CoomonStockMarketValue
|
2.89 | |
CY2021Q1 | ped |
Aggregate Intrinsic Value Of Options
AggregateIntrinsicValueOfOptions
|
250000 | USD |
CY2021Q4 | us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
52943 | shares |
CY2020Q1 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
1.68 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
1053000 | USD |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
|
0.0163 | pure |
CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P3Y6M | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
214000 | shares |
CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
2.00 | |
CY2021 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
266999 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.23 | |
CY2020 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
37500 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
75000 | shares |
CY2021Q4 | us-gaap |
Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
|
0.3088 | |
CY2021Q4 | ped |
Coomon Stock Market Value
CoomonStockMarketValue
|
1.05 | |
CY2021Q4 | ped |
Aggregate Intrinsic Value Of Options
AggregateIntrinsicValueOfOptions
|
56000 | USD |
CY2020Q1 | us-gaap |
Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
|
733000 | shares |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.55 | pure |
CY2020Q3 | us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
32012 | shares |
CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
37500 | shares |
CY2020Q3 | us-gaap |
Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
|
0.3088 | |
CY2020Q3 | ped |
Coomon Stock Market Value
CoomonStockMarketValue
|
2.11 | |
CY2020Q3 | ped |
Aggregate Intrinsic Value Of Options
AggregateIntrinsicValueOfOptions
|
68000 | USD |
CY2021 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
533000000 | USD |
CY2020 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
501000000 | USD |
CY2021Q4 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
287000 | USD |
CY2020Q4 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
315000 | USD |
CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | USD |
CY2020Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
121000000 | USD |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.43 | |
CY2021 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P2Y8M12D | |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
753349 | shares |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.93 | |
CY2020 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P2Y6M | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
550000 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.39 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
733000 | shares |
CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.68 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
394415 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
3.57 | |
CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.31 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1123435 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.80 | |
CY2021 | ped |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a
|
P3Y | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1234849 | shares |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.43 | |
CY2020 | ped |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a
|
P2Y8M12D | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
366101 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
2.42 | |
CY2021 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
|
P1Y8M12D | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
720016 | shares |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.08 | |
CY2020 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
|
P1Y7M6D | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | pure |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0664 | pure |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0664 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
|
0.0000 | pure |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
|
0.0000 | pure |
CY2021 | ped |
Meals And Entertainment
MealsAndEntertainment
|
-0.0003 | pure |
CY2020 | ped |
Meals And Entertainment
MealsAndEntertainment
|
0.0000 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
|
0.0795 | pure |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
|
0.0000 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
|
0.0573 | pure |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
|
0.0020 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.0650 | pure |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.0002 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.0000 | pure |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.0000 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.3633 | pure |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.2746 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.0000 | pure |
CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | pure |
CY2021Q4 | ped |
Deferred Tax Assets Difference In Depreciation Depletion And Capitalization Methods Oil And Natural Gas Properties
DeferredTaxAssetsDifferenceInDepreciationDepletionAndCapitalizationMethodsOilAndNaturalGasProperties
|
2389000 | USD |
CY2020Q4 | ped |
Deferred Tax Assets Difference In Depreciation Depletion And Capitalization Methods Oil And Natural Gas Properties
DeferredTaxAssetsDifferenceInDepreciationDepletionAndCapitalizationMethodsOilAndNaturalGasProperties
|
712000 | USD |
CY2021Q4 | ped |
Deferred Tax Assets Tax Accretion
DeferredTaxAssetsTaxAccretion
|
132000 | USD |
CY2020Q4 | ped |
Deferred Tax Assets Tax Accretion
DeferredTaxAssetsTaxAccretion
|
80000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
|
5343000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
|
5343000 | USD |
CY2021Q4 | us-gaap |
Lease Deposit Liability
LeaseDepositLiability
|
56 | USD |
CY2020Q4 | us-gaap |
Lease Deposit Liability
LeaseDepositLiability
|
0 | USD |
CY2021Q4 | ped |
Rou Assets
RouAssets
|
52 | USD |
CY2020Q4 | ped |
Rou Assets
RouAssets
|
0 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
|
1000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
|
1000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1149000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
975000 | USD |
CY2021Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
24422000 | USD |
CY2020Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
25507000 | USD |
CY2021Q4 | ped |
Net Operating Losses State Taxes
NetOperatingLossesStateTaxes
|
3531000 | USD |
CY2020Q4 | ped |
Net Operating Losses State Taxes
NetOperatingLossesStateTaxes
|
3874000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
|
36963000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
|
36492000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
36963000 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
36492000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2021 | ped |
Ownership Change Percent
OwnershipChangePercent
|
0.50 | pure |
CY2021 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
471000000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
116000000000 | USD |
CY2021 | us-gaap |
Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
|
95000000 | USD |
CY2021 | ped |
Not Utilized Will Begin Expiring In2038
NotUtilizedWillBeginExpiringIn2038
|
21000000 | USD |
CY2021 | ped |
Taxable Income Percent
TaxableIncomePercent
|
0.80 | pure |